{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:37:09Z","timestamp":1778218629912,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12HS026396"],"award-info":[{"award-number":["K12HS026396"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA044878"],"award-info":[{"award-number":["R01DA044878"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1K24DA051807"],"award-info":[{"award-number":["1K24DA051807"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RM1DA055437"],"award-info":[{"award-number":["RM1DA055437"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hospital-based clinicians infrequently initiate medications for opioid use disorder (MOUD) for hospitalized patients. Our objective was to understand hospital-based clinicians\u2019 knowledge, comfort, attitudes, and motivations regarding MOUD initiation to target quality improvement initiatives.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>General medicine attending physicians and physician assistants at an academic medical center completed questionnaires eliciting barriers to MOUD initiation, including knowledge, comfort, attitudes and motivations regarding MOUD. We explored whether clinicians who had initiated MOUD in the prior 12\u00a0months differed in knowledge, comfort, attitudes, and motivations from those who had not.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One-hundred forty-three clinicians completed the survey with 55% reporting having initiated MOUD for a hospitalized patient during the prior 12\u00a0months. Common barriers to MOUD initiation were: (1) Not enough experience (86%); (2) Not enough training (82%); (3) Need for more addiction specialist support (76%). Overall, knowledge of and comfort with MOUD was low, but motivation to address OUD was high. Compared to MOUD non-initiators, a greater proportion of MOUD initiators answered knowledge questions correctly, agreed or strongly agreed that they wanted to treat OUD (86% vs. 68%, p\u2009=\u20090.009), and agreed or strongly agreed that treatment of OUD with medication was more effective than without medication (90% vs. 75%, p\u2009=\u20090.022).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Hospital-based clinicians had favorable attitudes toward MOUD and are motivated to initiate MOUD, but they lacked knowledge of and comfort with MOUD initiation. To increase MOUD initiation for hospitalized patients, clinicians will need additional training and specialist support.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-023-00386-x","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T02:01:38Z","timestamp":1684375298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-5589","authenticated-orcid":false,"given":"Andrea","family":"Jakubowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumeet","family":"Singh-Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Torres-Lockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi","family":"Nahvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron D.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"386_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017. https:\/\/doi.org\/10.1136\/bmj.j1550.","journal-title":"BMJ"},{"key":"386_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0140-6736(09)61036-9","volume":"374","author":"PS Haber","year":"2009","unstructured":"Haber PS, Demirkol A, Lange K, Murnion B. Management of injecting drug users admitted to hospital. The Lancet. 2009;374:1284.","journal-title":"The Lancet"},{"issue":"4","key":"386_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/ADM.0000000000000499","volume":"13","author":"JL Moreno","year":"2019","unstructured":"Moreno JL, Wakeman SE, Duprey MS, Roberts RJ, Jacobson JS, Devlin JW. Predictors for 30-day and 90-day hospital readmission among patients with opioid use disorder. J Addict Med. 2019;13(4):306\u201313.","journal-title":"J Addict Med"},{"key":"386_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.04.025","author":"S Jason Wang","year":"2020","unstructured":"Jason Wang S, Wade E, Towle J, Hachey T, Rioux J, Samuels O, et al. Effect of inpatient medication-assisted therapy on against-medical-advice discharge and readmission rates. Am J Med. 2020. https:\/\/doi.org\/10.1016\/j.amjmed.2020.04.025.","journal-title":"Am J Med"},{"issue":"4","key":"386_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jsat.2012.03.008","volume":"43","author":"R Schwarz","year":"2021","unstructured":"Schwarz R, Zelenev A, Bruce RD, Altice FL. Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. J Subst Abuse Treat. 2021;43(4):451\u20137.","journal-title":"J Subst Abuse Treat"},{"key":"386_CR6","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. HHS Publ No PEP21-07-01-003. 2020;NSDUH Seri. https:\/\/www.samhsa.gov\/data\/"},{"issue":"3","key":"386_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.12788\/jhm.3311","volume":"15","author":"H Englander","year":"2020","unstructured":"Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A call to action: hospitalists\u2019 role in addressing substance use disorder. J Hosp Med. 2020;15(3):184\u20137.","journal-title":"J Hosp Med"},{"key":"386_CR8","unstructured":"Weiss AJ, Heslin KC, Stocks C, Owens PL. Hospital inpatient stays related to opioid use disorder and endocarditis, 2016. Healthc Cost Util Proj Stat Briefs. 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557173\/. Accessed 17 Sep 2019."},{"issue":"16","key":"386_CR9","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","volume":"313","author":"G D\u2019Onofrio","year":"2015","unstructured":"D\u2019Onofrio G, O\u2019Connor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA\u2014J Am Med Assoc. 2015;313(16):1636\u201344. https:\/\/doi.org\/10.1001\/jama.2015.3474.","journal-title":"JAMA\u2014J Am Med Assoc"},{"issue":"1","key":"386_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10550490500418989","volume":"15","author":"RM Caldiero","year":"2006","unstructured":"Caldiero RM, Parran TV, Adelman CL, Piche B. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved? Am J Addict. 2006;15(1):1\u20137.","journal-title":"Am J Addict"},{"issue":"8","key":"386_CR11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369\u201376.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"386_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiat. 2021;78(9):979\u201393.","journal-title":"JAMA Psychiat"},{"issue":"1\u20132","key":"386_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","volume":"105","author":"L Degenhardt","year":"2009","unstructured":"Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009;105(1\u20132):9\u201315.","journal-title":"Drug Alcohol Depend"},{"issue":"7779","key":"386_CR14","first-page":"928","volume":"341","author":"R Cornish","year":"2010","unstructured":"Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK general practice research database. BMJ. 2010;341(7779):928.","journal-title":"BMJ"},{"issue":"8","key":"386_CR15","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","volume":"35","author":"KC Priest","year":"2020","unstructured":"Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. opioid agonist therapy during hospitalization within the veterans health administration: a pragmatic retrospective cohort analysis. J Gen Intern Med. 2020;35(8):2365\u201374.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"386_CR16","first-page":"1273","volume":"34","author":"L Gelberg","year":"2000","unstructured":"Gelberg L, Andersen RM, Leake BD. The Behavioral Model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273\u2013302.","journal-title":"Health Serv Res"},{"key":"386_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","volume":"131","author":"LC Van Boekel","year":"2013","unstructured":"Van Boekel LC, Brouwers EPM, Van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131:23\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"386_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08897077.2020.1748169","volume":"43","author":"SL Calcaterra","year":"2022","unstructured":"Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O\u2019Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: a survey of hospitalist physicians. Subst Abus. 2022;43(1):143\u201351. https:\/\/doi.org\/10.1080\/08897077.2020.1748169.","journal-title":"Subst Abus"},{"issue":"4","key":"386_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/08897077.2016.1187240","volume":"37","author":"SE Wakeman","year":"2016","unstructured":"Wakeman SE, Pham-Kanter G, Donelan K. Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists. Subst Abus. 2016;37(4):635\u201341. https:\/\/doi.org\/10.1080\/08897077.2016.1187240.","journal-title":"Subst Abus"},{"issue":"5","key":"386_CR20","doi-asserted-by":"publisher","first-page":"e204561","DOI":"10.1001\/jamanetworkopen.2020.4561","volume":"3","author":"KF Hawk","year":"2020","unstructured":"Hawk KF, D\u2019Onofrio G, Chawarski MC, O\u2019Connor PG, Cowan E, Lyons MS, et al. Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine. JAMA Netw open. 2020;3(5):e204561.","journal-title":"JAMA Netw open"},{"issue":"9","key":"386_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ajem.2019.02.025","volume":"37","author":"M Lowenstein","year":"2019","unstructured":"Lowenstein M, Kilaru A, Perrone J, Hemmons J, Abdel-Rahman D, Meisel ZF, et al. Barriers and facilitators for emergency department initiation of buprenorphine: a physician survey. Am J Emerg Med. 2019;37(9):1787\u201390.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"386_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1037\/0893-164X.10.2.81","volume":"10","author":"WR Miller","year":"1996","unstructured":"Miller WR, Tonigan JS. Assessing drinkers\u2019 motivation for change: the stages of change readiness and treatment eagerness scale (SOCRATES). Psychol Addict Behav. 1996;10(2):81\u20139.","journal-title":"Psychol Addict Behav"},{"key":"386_CR23","unstructured":"Centers for Disease Control and Prevention. Synthetic Opioid Overdose Data | Drug Overdose | CDC Injury Center [Internet]. Centers for Disease Control and Prevention. 2020. https:\/\/www.cdc.gov\/drugoverdose\/deaths\/synthetic\/index.html. Accessed 12 Sep 2022."},{"issue":"6","key":"386_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"386_CR25","first-page":"752","volume":"13","author":"H Englander","year":"2018","unstructured":"Englander H, Collins D, Peterson Perry S, Rabinowitz M, Phoutrides E, Nicolaidis C. \u201cWe\u2019ve learned it\u2019s a medical illness, not a moral choice\u201d: qualitative study of the effects of a multicomponent addiction intervention on hospital providers\u2019 attitudes and experiences. An Off Publ Soc Hosp Med J Hosp Med. 2018;13:752.","journal-title":"An Off Publ Soc Hosp Med J Hosp Med"},{"key":"386_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/26334895221096290","volume":"3","author":"KD Williams","year":"2022","unstructured":"Williams KD, Wilson BL, Jurkovitz CT, Melson JA, Reitz JA, Pal CK, et al. Implementation of a clinical pathway to screen and treat medical inpatients for opioid withdrawal. Implement Res Practice. 2022;3:1\u201322.","journal-title":"Implement Res Practice"},{"issue":"8","key":"386_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/acem.14002","volume":"27","author":"WC Holland","year":"2020","unstructured":"Holland WC, Nath B, Li F, Maciejewski K, Paek H, Dziura J, et al. Interrupted time series of user-centered clinical decision support implementation for emergency department\u2013initiated buprenorphine for opioid use disorder. Acad Emerg Med. 2020;27(8):753\u201363.","journal-title":"Acad Emerg Med"},{"key":"386_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000926","author":"K Butler","year":"2021","unstructured":"Butler K, Chavez T, Wakeman S, Robertson T, Leifer J, Barofsky J, et al. Nudging emergency department initiated addiction treatment. J Addict Med. 2021. https:\/\/doi.org\/10.1097\/ADM.0000000000000926.","journal-title":"J Addict Med"},{"issue":"4","key":"386_CR29","first-page":"1","volume":"6","author":"G D'Onofrio","year":"2023","unstructured":"D'Onofrio G, Edelman EJ, Hawk KF, Chawarski MC, Pantalon MV, Owens PH. Implementation facilitation to promote emergency department\u2014initiated buprenorphine for opioid use disorder. JAMA Netw Open. 2023;6(4):1\u201315.","journal-title":"JAMA Netw Open"},{"key":"386_CR30","doi-asserted-by":"publisher","first-page":"108248","DOI":"10.1016\/j.jsat.2020.108248","volume":"122","author":"JF Magidson","year":"2021","unstructured":"Magidson JF, Regan S, Powell E, Jack HE, Herman GE, Zaro C, et al. Peer recovery coaches in general medical settings: changes in utilization, treatment engagement, and opioid use. J Subst Abuse Treat. 2021;122:108248.","journal-title":"J Subst Abuse Treat"},{"issue":"7","key":"386_CR31","doi-asserted-by":"publisher","first-page":"899","DOI":"10.7326\/M20-5475","volume":"174","author":"J Gryczynski","year":"2021","unstructured":"Gryczynski J, Nordeck CD, Welsh C, Mitchell SG, O\u2019Grady KE, Schwartz RP. Preventing hospital readmission for patients with comorbid substance use disorder\u202f: a randomized trial. Ann Intern Med. 2021;174(7):899\u2013909.","journal-title":"Ann Intern Med"},{"issue":"1","key":"386_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/08897077.2021.1949663","volume":"43","author":"R French","year":"2022","unstructured":"French R, Aronowitz SV, Brooks Carthon JM, Schmidt HD, Compton P. Interventions for hospitalized medical and surgical patients with opioid use disorder: a systematic review. Subst Abus. 2022;43(1):495\u2013507. https:\/\/doi.org\/10.1080\/08897077.2021.1949663.","journal-title":"Subst Abus"},{"issue":"4","key":"386_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jsat.2007.05.009","volume":"34","author":"RJ Roose","year":"2008","unstructured":"Roose RJ, Kunins HV, Sohler NL, Elam RT, Cunningham CO. Nurse practitioner and physician assistant interest in prescribing buprenorphine. J Subst Abuse Treat. 2008;34(4):456\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"386_CR34","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1377\/hlthaff.2019.00859","volume":"38","author":"ML Barnett","year":"2019","unstructured":"Barnett ML, Lee D, Frank RG. In rural areas, buprenorphine waiver Adoption since 2017 driven by nurse practitioners and physician assistants. Health Aff. 2019;38(12):2048\u201356. https:\/\/doi.org\/10.1377\/hlthaff.2019.00859.","journal-title":"Health Aff"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00386-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00386-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00386-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T02:04:36Z","timestamp":1684375476000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00386-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00386-x","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was deemed exempt by the Albert Einstein College of Medicine Institutional Review Board (Reference number: 093870).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}